OSR Health, Inc. (OSRHW) Common Equity (2021 - 2026)

OSR Health (OSRHW) has 6 years of Common Equity data on file, last reported at $127.4 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 3.7% year-over-year to $127.4 million; the trailing twelve-month figure through Mar 2026 stood at $127.4 million (down 3.7% YoY), and the FY2025 full-year result was $127.0 million, down 11.29% from the prior year.
• Common Equity steadied at $127.4 million in Q1 2026, from $127.0 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $153.5 million in Q4 2023 to a low of -$2.5 million in Q3 2023.
• A 5-year average of $76.3 million and a median of $91.6 million in 2024 frame the typical range for Common Equity.
• Peak annual rise in Common Equity reached 409310.4% in 2023, while the deepest fall reached 64665.28% in 2023.
• Tracing OSRHW's Common Equity over 5 years: stood at -$37508.0 in 2022, then surged by 409310.4% to $153.5 million in 2023, then declined by 6.7% to $143.2 million in 2024, then decreased by 11.29% to $127.0 million in 2025, then rose by 0.28% to $127.4 million in 2026.
• Business Quant data shows OSRHW's Common Equity at $127.4 million in Q1 2026, $127.0 million in Q4 2025, and $134.2 million in Q3 2025.